reuteurs ^ | MARCH 22, 2020 | Michael Erman 3 MIN READ
At least four state pharmacy boards have taken steps to limit prescriptions of potential coronavirus treatments touted by U.S. President Donald Trump that are in short supply as demand has surged with the rapid spread of the outbreak.